Funding for this research was provided by:
Japan Society for the Promotion of Science (20K18385)
Article History
Received: 5 April 2023
Revised: 28 June 2023
Accepted: 23 July 2023
First Online: 3 August 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committee of the Faculty of Medicine, University of Miyazaki and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Research Ethics Committee of the Faculty of Medicine, University of Miyazaki (study number: O-0670).
: All patients provided informed consent and public announcements of this study were performed. Details of the study were made available on the university website.
: Hidaka T and Chuman H certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.Ikeda Y has received financial support from Alcon Japan Ltd., Senju Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., HOYA Corporation, Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., and Ellex, Inc. Ikeda Y has received personal financial interest from Vixion Corporation. Ikeda Y has served as a consultant for Novartis Pharma K.K., HOYA Corporation, and Vixion Corporation. Ikeda Y has a patent to ID Pharma Co., Ltd. Ikeda Y has received royalties from Bayer Yakuhin, Ltd., Kowa Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Vixion Corporation, Chugai Pharmaceutical Co., Ltd., NIDEK Co., Ltd., HOYA Corporation, Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., and Novartis Pharma K.K.